Document is current

Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways

Crossref DOI link: https://doi.org/10.17352/gjct.000009

Published Online: 2016-07-02

Update policy: https://doi.org/10.17352/crossmark-policy